We invest early in people building innovative and disruptive technologies for human health, the future-of-work, and the infrastructure that powers them both. Our broad investment thesis allows us to see a wide variety of companies, and pick those with the greatest potential for global impact, led by the best founders. We typically write $100K - $2M first checks into pre-Series A rounds, and are comfortable either leading or participating.